BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27175594)

  • 41. The Role of IRX Homeobox Genes in Hematopoietic Progenitors and Leukemia.
    Nagel S
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Normal and Aberrant TALE-Class Homeobox Gene Activities in Pro-B-Cells and B-Cell Precursor Acute Lymphoblastic Leukemia.
    Nagel S; Meyer C
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia.
    Külp M; Siemund AL; Larghero P; Dietz A; Alten J; Cario G; Eckert C; Caye-Eude A; Cavé H; Bardini M; Cazzaniga G; De Lorenzo P; Valsecchi MG; Diehl L; Bonig H; Meyer C; Marschalek R
    iScience; 2022 Jul; 25(7):104613. PubMed ID: 35800767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Hematopoietic TALE-Code Shows Normal Activity of IRX1 in Myeloid Progenitors and Reveals Ectopic Expression of IRX3 and IRX5 in Acute Myeloid Leukemia.
    Nagel S; Pommerenke C; Meyer C; MacLeod RAF
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genome-wide aberrant methylation in primary metastatic UM and their matched metastases.
    Smit KN; Boers R; Vaarwater J; Boers J; Brands T; Mensink H; Verdijk RM; van IJcken WFJ; Gribnau J; de Klein A; Kilic E
    Sci Rep; 2022 Jan; 12(1):42. PubMed ID: 34997020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program.
    Rice S; Jackson T; Crump NT; Fordham N; Elliott N; O'Byrne S; Fanego MDML; Addy D; Crabb T; Dryden C; Inglott S; Ladon D; Wright G; Bartram J; Ancliff P; Mead AJ; Halsey C; Roberts I; Milne TA; Roy A
    Nat Commun; 2021 Nov; 12(1):6905. PubMed ID: 34824279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia.
    de Barrios O; Parra M
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic Inactivation of the Tumor Suppressor
    Küster MM; Schneider MA; Richter AM; Richtmann S; Winter H; Kriegsmann M; Pullamsetti SS; Stiewe T; Savai R; Muley T; Dammann RH
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33256112
    [No Abstract]   [Full Text] [Related]  

  • 49. Prognostic value of Iroquois homeobox 1 methylation in non-small cell lung cancers.
    Lee JY; Lee WK; Park JY; Kim DS
    Genes Genomics; 2020 May; 42(5):571-579. PubMed ID: 32200543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Another piece of the puzzle added to understand t(4;11) leukemia better.
    Marschalek R
    Haematologica; 2019 Jun; 104(6):1098-1100. PubMed ID: 31152087
    [No Abstract]   [Full Text] [Related]  

  • 51. Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between
    Bueno C; Calero-Nieto FJ; Wang X; Valdés-Mas R; Gutiérrez-Agüera F; Roca-Ho H; Ayllon V; Real PJ; Arambilet D; Espinosa L; Torres-Ruiz R; Agraz-Doblas A; Varela I; de Boer J; Bigas A; Gottgens B; Marschalek R; Menendez P
    Haematologica; 2019 Jun; 104(6):1189-1201. PubMed ID: 30679325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis.
    Agraz-Doblas A; Bueno C; Bashford-Rogers R; Roy A; Schneider P; Bardini M; Ballerini P; Cazzaniga G; Moreno T; Revilla C; Gut M; Valsecchi MG; Roberts I; Pieters R; De Lorenzo P; Varela I; Menendez P; Stam RW
    Haematologica; 2019 Jun; 104(6):1176-1188. PubMed ID: 30679323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction.
    Somers K; Wen VW; Middlemiss SMC; Osborne B; Forgham H; Jung M; Karsa M; Clifton M; Bongers A; Gao J; Mayoh C; Raoufi-Rad N; Kusnadi EP; Hannan KM; Scott DA; Kwek A; Liu B; Flemming C; Chudakova DA; Pandher R; Failes TW; Lim J; Angeli A; Osterman AL; Imamura T; Kees UR; Supuran CT; Pearson RB; Hannan RD; Davis TP; McCarroll J; Kavallaris M; Turner N; Gudkov AV; Haber M; Norris MD; Henderson MJ
    Oncogene; 2019 May; 38(20):3824-3842. PubMed ID: 30670779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis.
    Trentin L; Bresolin S; Giarin E; Bardini M; Serafin V; Accordi B; Fais F; Tenca C; De Lorenzo P; Valsecchi MG; Cazzaniga G; Kronnie GT; Basso G
    Sci Rep; 2016 Oct; 6():34449. PubMed ID: 27698462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The IRX1/HOXA connection: insights into a novel t(4;11)- specific cancer mechanism.
    Kühn A; Löscher D; Marschalek R
    Oncotarget; 2016 Jun; 7(23):35341-52. PubMed ID: 27175594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HOXA9/IRX1 expression pattern defines two subgroups of infant MLL-AF4-driven acute lymphoblastic leukemia.
    Symeonidou V; Ottersbach K
    Exp Hematol; 2021 Jan; 93():38-43.e5. PubMed ID: 33069783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
    Gessner A; Thomas M; Castro PG; Büchler L; Scholz A; Brümmendorf TH; Soria NM; Vormoor J; Greil J; Heidenreich O
    Leukemia; 2010 Oct; 24(10):1751-9. PubMed ID: 20686504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification.
    Bueno C; Montes R; Melen GJ; Ramos-Mejia V; Real PJ; Ayllón V; Sanchez L; Ligero G; Gutierrez-Aranda I; Fernández AF; Fraga MF; Moreno-Gimeno I; Burks D; Plaza-Calonge Mdel C; Rodríguez-Manzaneque JC; Menendez P
    Cell Res; 2012 Jun; 22(6):986-1002. PubMed ID: 22212479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular mechanisms of MLL-associated leukemia.
    Yokoyama A
    Int J Hematol; 2015 Apr; 101(4):352-61. PubMed ID: 25773519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.
    Bueno C; Montes R; Catalina P; Rodríguez R; Menendez P
    Leukemia; 2011 Mar; 25(3):400-10. PubMed ID: 21135858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.